Skip to main content
. 2022 May 30;8(2):118–124. doi: 10.5114/ceh.2022.115056

Table 5.

Comparison of the data of the 4 improved patients to those who did not improve

Parameter Mean SD T P value CI Lower CI Upper
BMI No response 37.19 6.649
Improved steatosis 33.27 1.12 4.41 ≤ 0.01 2.04 5.78
Waist No response 114.87 12.19
Improved steatosis 106.5 4.43 3.28 ≤ 0.01 1.9 14.84
Hip No response 117.13 11.7
Improved steatosis 112.5 1.0 3.55 ≤ 0.01 2.03 7.24
BSF No response 0.45 0.12
Improved steatosis 0.32 0.05 4.62 ≤ 0.01 0.05 0.2
ALT No response 36.92 20.51
Improved steatosis 27.52 3.69 3.34 ≤ 0.01 3.41 15.38
AST No response 38.8 19.97
Improved steatosis 30.75 3.45 2.99 ≤ 0.01 2.37 13.73
APRI No response 0.61 0.336
Improved steatosis 0.5 0.068 2.4 ≤ 0.01 0.01 0.22

BMI – body mass index, BSF – biceps skin fold, ALT – alanine transaminase, AST – aspartate transaminase